Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sernova Corp
T.SVA
Alternate Symbol(s):
SEOVF
Healthcare
Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a...
novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:SVA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Nov 21, 2024 6:55am
Buzz on the Bullboards: Bombardier, world woes, a smart fridge, and top shelf weed
A highlight of the week was Bombardier (TSX:BBD), which reported impressive growth in its Q3 2024 results.
read article.
(6)
•••
edrose
X
View Profile
View Bullboard History
Post by
edrose
on Nov 15, 2024 7:01am
loooking at this company it's been taking them years
to enroll patients and it takes years to get data to get fda or hpb in canada to see if they would approve this treatment which would help thousands of type 1 diabetics
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 23, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(5)
•••
palladium17
X
View Profile
View Bullboard History
Comment by
palladium17
on Nov 09, 2024 2:33pm
RE:RE:RE:this board
RixPix you are right it is very little.
(134)
•••
rixpix
X
View Profile
View Bullboard History
Comment by
rixpix
on Nov 01, 2024 7:45am
RE:RE:this board
Half a million shares shorted is nothing for SVA. A Private Placement was done 2 months ago so having some shares shorted is nothing important. GL.
(134)
•••
rixpix
X
View Profile
View Bullboard History
Comment by
rixpix
on Nov 01, 2024 7:40am
RE:this board
Hey WK. They've moved on, but not because they sold. They're all on another site. CEO . Ca. Bioteck signed up as RixPix before I went there and I'm there too now.
(100)
•••
bbowles
X
View Profile
View Bullboard History
Comment by
bbowles
on Oct 29, 2024 12:03pm
RE:this board
Yep everyone has left this submarine except for the shorts. Number of Shares Shorted Net Change Oct 15, 2024 593,320 175,757
(413)
•••
woundedknee
X
View Profile
View Bullboard History
Post by
woundedknee
on Oct 29, 2024 9:09am
this board
This board is no fun. Where did all the posters go from a couple of years ago? You know, the ones critisizing "spillup". Obviously they have sold and moved on. This is my second go around
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 11, 2024 7:32am
New Press Release - Sernova Announces Key New Executive Appointments
(TheNewswire) Experienced leadership team positions company to advance Cell Pouch™ bio-hybrid organ programs. LONDON, Ontario; BOSTON, Massachusetts – TheNewswire – October 11, 2024 – Sernova Corp. (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company currently...
read article.
(134)
•••
rixpix
X
View Profile
View Bullboard History
Comment by
rixpix
on Oct 05, 2024 8:28am
RE:RE:RE:Bought a few
I'm still in Europe so it's hard to follow anything that's EST based, but no, I didn't notice because I never follow any stock hourly. Good job in buying more. I think it was a wise
...more
(413)
•••
woundedknee
X
View Profile
View Bullboard History
Comment by
woundedknee
on Oct 03, 2024 11:38am
RE:RE:Bought a few
Hi rixpix...just bought 120k today rounding out at 150. Hope you noticed the little uptik
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 03, 2024 7:30am
New Press Release - Sernova to Present at the 2024 Cell & Gene Meeting on the Mesa
(TheNewswire)LONDON, Ontario; BOSTON, Massachusetts –October 3, 2024 – TheNewswire – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatment of chronic diseases,announced that...
read article.
(134)
•••
rixpix
X
View Profile
View Bullboard History
Comment by
rixpix
on Sep 29, 2024 4:02pm
RE:Bought a few
Hey WK. Welcome back as a shareholder. While you bought a few, I bought more through the latest PP. I think you'll do fine, but I've been wrong before. GL
(413)
•••
woundedknee
X
View Profile
View Bullboard History
Post by
woundedknee
on Sep 23, 2024 3:50pm
Bought a few
Naturally, most traded on the grays. Only in for 30k at .25 and .255 Not many of the old posters left.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 19, 2024 7:30am
New Press Release - Sernova Appoints David Paterson Ph.D. to its Board of Directors
(TheNewswire)LONDON, Ontario; BOSTON, Massachusetts – September 19, 2024 – TheNewswire – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatment of chronic diseases, announces...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 12, 2024 8:00am
New Press Release - Sernova Announces New Positive Data from Phase I/II Trial Regarding Islet Survival and Function
Abundant, richly vascularized and functioning islets observed throughout all chambers of Sernova’s Cell Pouch more than 5 years after islet transplantation Histological data confirmation of healthy beta, alpha and delta cells secreting insulin, glucagon, and somatostatin in all Cell Pouch...
read article.
(134)
•••
rixpix
X
View Profile
View Bullboard History
Post by
rixpix
on Sep 05, 2024 7:18pm
33 cents close is the previous PP price
The PP that was cancelled. Good to see SVA back at .33 in such a short period of time.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >